GlobalData on MSN
AbbVie announces $380m investment in North Chicago API facilities
Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.
The industry is buzzing about AI agents that could automate this work. But here’s what most companies miss: You can’t hand ...
AbbVie (NYSE: ABBV) today announced a new $380 million investment to build two new active pharmaceutical ingredient (API) manufacturing facilities at its current North Chicago, Illinois, campus. These ...
Feb 23 (Reuters) - AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient ...
In this forward-looking whitepaper, Blue Mountain explores how agentic AI —autonomous, context-aware AI agents—could ...
The Daily Caller on MSNOpinion
Gavin M Wax: Trump quietly set up future of American manufacturing with stroke of a pen
After the Supreme Court’s ruling Friday that the International Emergency Economic Powers Act does not authorize the president ...
Key TakeawaysDigital twins are ultra-accurate computer-based simulations of complex physical systems used for exploring "what ...
Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable treatments, today announced that it will ...
Discusses Portfolio Strategy, Recent Exits, and Focus on Deep Tech and Defense Investments February 18, 2026 4:00 AM ...
Anthropic's Claude Sonnet 4.6 matches Opus 4.6 performance at 1/5th the cost. Released while the India AI Impact Summit is on, it is the important AI model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results